Bausch Health Companies Inc is experiencing a notable decline in its stock price, raising concerns among investors.
Bausch Health Companies Inc (BHC.TO) is having a tough trading day, with its stock dropping by 4.32% to close at CA$8.42. This decline follows a brief surge after positive earnings reports, leaving investors questioning whether these recent gains can last.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Bausch Health Companies Inc
BHC.TO
BHC.TO
Bausch Health Companies Inc
WealthAwesomeMarket cap
$3.39B
52W high
$11.97
52W low
$6.10
1W change
+34.15%
Beta
0.38
Analyst Price Targets
Based on analyst covering BHC
Wall Street analysts forecast BHC stock price to fall 20.4% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.01
-20.4% Upside
Current Price
C$8.80
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BHC's historical volatility
30-Day Vol
96.2%
Annualized
90-Day Vol
64.4%
Annualized
Trend (90d)
+46.4%
Annualized drift
90d Mean
C$10.39
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$9.30 | C$6.67 – C$12.96 |
| 60 trading days | C$9.83 | C$6.15 – C$15.71 |
| 90 trading days | C$10.39 | C$5.84 – C$18.45 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Despite recent earnings growth, Bausch Health's stock is under pressure, highlighting the volatility and uncertainty surrounding its recovery strategy.
Bausch Health's stock down 4.32% today
The company has lost 32.7% year-to-date, significantly underperforming compared to its industry.
Bull case
Bausch Health recently reported a strong second quarter, with revenues up 12.7% and a turnaround in net income. This could signal potential for future growth if the company manages its resources effectively.
Bear case
Investor caution is clear as institutional participation has decreased, indicating a lack of confidence in Bausch Health's ability to maintain its recovery trajectory.
Recent Performance Overview
Advertisement
Bausch Health's stock has faced significant volatility, losing 32.7% year-to-date. The recent 4.32% drop follows a strong earnings report that initially boosted investor sentiment. However, this decline suggests that market confidence may be wavering as institutional investors reduce their holdings.
Earnings Report Highlights
In its latest earnings report, Bausch Health announced a net income of $260 million, a significant increase from the previous year. Revenue growth of 12.7% was driven by strong performance in its Salix and Solta Medical segments. Despite these positive figures, the stock's recent decline indicates that investors are cautious about the company's long-term profitability and growth strategy.
Institutional Investor Sentiment
Data shows a notable drop in institutional participation, with hedge fund holdings decreasing by 24.4%. This trend signals a lack of confidence among larger investors regarding Bausch Health's ability to sustain its recovery. As the company navigates its turnaround strategy, continued scrutiny from the market may impact its stock performance.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
